公司需求幾篇藥品文獻(xiàn)資料。臨床應(yīng)用數(shù)據(jù)。具體產(chǎn)品私信我找到一篇50元   [更多]

需要地奧司明英國(guó)藥典的標(biāo)準(zhǔn)。 BP2017或者BP2018 或者2019都可以。   [更多]

求購(gòu)“Talc”《 EP9.2 》的藥典標(biāo)準(zhǔn)一份 需求名稱：Talc”《 EP9.2 》 要求時(shí)間：請(qǐng)?jiān)?019年4月16號(hào)之前   [更多]

標(biāo)題：求購(gòu)"Appendices: Talc”《 BP2019 》的藥典標(biāo)準(zhǔn)一份 需求名稱：Appendices: Talc”《 BP2019 》 要求時(shí)間：請(qǐng)?jiān)?019年4月16號(hào)之前   [更多]

求購(gòu) “Talc”《 JP17(英) 》的藥典標(biāo)準(zhǔn)一份. 需求名稱：“Talc”《 JP17(英) 》 要求時(shí)間：請(qǐng)?jiān)?019年4月16號(hào)之前   [更多]

需求幾十篇文獻(xiàn) 1.Regulation Mechanism of MicroRNAs in Non-Small Cell Lung Cancer 2、J Clin Gastroenterol. 2016 Jan;50(1):e1-7. Gastroesophageal Reflux Disease: Cross-Sectional Study Demonstrating Rising Prevalence in a Chinese Population. Tan VP1, Wong BC, Wong WM, Leung WK, Tong D, Yuen MF, Fass R. 3、Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, Bazzoli F, Ford AC. Gut. 2018 Mar;67(3):430-440. 4、The prevalence and risk factors of reflux esophagitis among adult Chinese population in Taiwan. Chen TS, Chang FY. J Clin Gastroenterol. 2007 Oct;41(9):819-22. 5、 Circulation. 1998 Nov 24;98(21):2282-9. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Senni M1, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, Redfield MM. 6、 Anesth Analg. 2018 Nov 9. doi: 10.1213/ANE.0000000000003887. [Epub ahead of print] Side Effect Rates of Opioids in Equianalgesic Doses Via Intravenous Patient-Controlled Analgesia: A Systematic Review and Network Meta-analysis. 7. Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD 8.Macromolecules, 1983, 16 (8), pp 1367-1374DOI: 10.1021/ma00242a019 Publication Date: August 1983 ACS Legacy Archive 9、Beneficial effects of tolvaptan on atrial remodeling induced by chronic intermittent hypoxia in rats Kai Zhang Zuowang Ma Weiding Wang Ruimeng Liu Yue Zhang Meng Yuan Guangping Li 10、Vascular. 2018 Dec;26(6):626-633. Prognostic factors of ulcer healing and amputation-free survival in patients with critical limb ischemia. 嚴(yán)重肢體缺血患者潰瘍愈合和無(wú)截肢生存的預(yù)后因素 Furuyama T, Onohara T, Yamashita S, Yoshiga R, Yoshiya K, Inoue K, Morisaki K, Kyuragi R, Matsumoto T, Maehara Y. 11、Curr Drug Discov Technol. 2018 Oct 8. Aripiprazole: An FDA Approved Bioactive Compound to treat schizophrenia-A Mini Review.   [更多]

1.Studies on the synergism of sulbactam and beta-lactam antibiotics under in vitro conditions and in healthy volunteers after intravenous administration. Antibacterial activity in vitro, compatibility and pharmacokinetics of the drugs in combination 2.Review of activity and therapeutic use of sulbactam with ampicillin: D. M. Campoli-Richards, R. N. Brogden, Drugs 33, 577-609 (1987). 3.中藥大品種科技競(jìng)爭(zhēng)力報(bào)告 2018版 4.Comparisons of synthetic 1-18 ACTH (Organon 2001) and 1-39 ACTH of animal origin in human subjects. Behav Neuropsychiatry. 1976 Apr-1977 Mar;8(1-12):3-5. 5. Chem.Abstr.1961# 24578 6. Doklady TSKhA1960vol. 52p. 443,444-450 7. 4.Perez-Ruiz F, Hingorani V, Welp J, et al. Efficacy and safety of a range of doses of RDEA594, a novel uricosuric agent, as a single agent in hyperuricemic gout patients: multicenter, randomized, double-blind, placebo-controlled, phase 2 experience [J]. Ann Rheum Dis, 2010, 69(Suppl 3): 121 8. 化學(xué)療法の領(lǐng)域（） 名稱：Stability of cefoperazone By: Takakura, Isamu; Kokei, Tetsuo; Watanabe, Keiko Source: Kagaku Ryoho no Ryoiki（化學(xué)療法の領(lǐng)域）, Volume: 6, Issue: 2, Pages: 324-34, Journal, 1990, CODEN: KRRYEI, ISSN: 0913-2384 Company/Organization: Toyama Kagaku Kogyo K. K., Japan   [更多]

標(biāo)題：重金求購(gòu)Amisulpride Tablets”《 BP2017 》的藥典標(biāo)準(zhǔn)一份. 詳細(xì)要求： 需求名稱：Amisulpride Tablets”《 BP2017 》的藥典標(biāo)準(zhǔn)一份. 具體要求：這里列出您的需求 要求時(shí)間：請(qǐng)?jiān)?019年03月30日之前 交稿方式：直接點(diǎn)擊交稿在線交稿就是了，我會(huì)每天過來看的，謝謝各位藥智的戰(zhàn)友們   [更多]

標(biāo)題：重金求購(gòu)Amisulpride”《 BP2017 》的藥典標(biāo)準(zhǔn) 詳細(xì)要求： 需求名稱：Amisulpride”《 BP2017 》的藥典標(biāo)準(zhǔn) 具體要求：這里列出您的需求 要求時(shí)間：請(qǐng)?jiān)?019年3月之前 交稿方式：直接點(diǎn)擊交稿在線交稿就是了，我會(huì)每天過來看的，謝謝各位藥智的戰(zhàn)友們   [更多]

ID：嘻嘻嘻嘿嘿嘿，領(lǐng)取賞金；處理統(tǒng)計(jì)之后藥智網(wǎng)未收載的說明書數(shù)量為23條，已收載的說明書條數(shù)為47條，總的賞金=23*5+47*3=256   [更多]